news Predatory bacteria may be a potentially safe alternative to antibioticsBy Dr Zara Kassam (Drug Target Review)
news BTSA1 causes cancer to self-destruct without affecting healthy cellsBy Dr Zara Kassam (Drug Target Review)
news TREM2 gene mutation poses both risk and benefits in Alzheimer’s diseaseBy Dr Zara Kassam (Drug Target Review)
news Link between bacterial imbalances and breast cancer identifiedBy Dr Zara Kassam (Drug Target Review)
news DNA-based Zika vaccine found effective at inducing immune responseBy Dr Zara Kassam (Drug Target Review)
news NRF2 pathway provides new approach to cancer drug discoveryBy Dr Zara Kassam (Drug Target Review)
news Scientists develop broad-spectrum inhibitors of influenza virusBy Dr Zara Kassam (Drug Target Review)
news Novartis and UC Berkeley collaborate to tackle ‘undruggable’ disease targetsBy Dr Zara Kassam (Drug Target Review)
news CYC065-eribulin combination therapy for triple-negative breast cancer identifiedBy Dr Zara Kassam (Drug Target Review)
news Potential therapeutic protein inhibitors for Chagas diseaseBy Dr Zara Kassam (Drug Target Review)
news Bryostatin-1 shows early promise for dormant HIV infectionBy Dr Zara Kassam (Drug Target Review)
news A fat-regulating enzyme could hold the key to diabetes and cancerBy Dr Zara Kassam (Drug Target Review)
article Structure based drug discovery facilitated by crystallographyBy Dr Sheraz Gul, Dr Sophie Zimmermann
news Antibiotic identified that reduces infection risk in young leukaemia patientsBy Dr Zara Kassam (Drug Target Review)
news Magnetic cellular ‘Legos’ for the regenerative medicine of the futureBy Dr Zara Kassam (Drug Target Review)
Follow: